Archive: 13/10/2016
Sitagliptin + metformin in type 2 diabetes: Added benefit over sulfonylurea + metformin
Sitagliptin (trade names: Januvia and Xelevia) is approved for certain adults with type 2 diabetes mellitus whose blood-glucose levels are inadequately controlled by diet and exercise alone. The fixed combination with metformin ...
Oct 13, 2016
Outwitting the 'silent thief' of osteoporosis
In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis. The findings, which arise from Australia's globally-recognised Dubbo ...
Oct 13, 2016
It's time to consider propranolol as an anti-cancer drug, researchers say
Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study published in ecancermedicalscience.
Oct 13, 2016
Bladder cancer clinical trial opens to patients
A bladder cancer clinical trial led by scientists at the University of Sheffield and funded by Yorkshire Cancer Research is now recruiting patients.
Oct 13, 2016